Showing results (491-500 of 1,155) with videos related to
Sort By:
Pageof 116
Journal of Neuroimmunology|July 1, 1996
Strong association of the third hypervariable region of HLA-DR beta 1 with autismR P Warren, J D Odell, W L Warren, et al.BMC Genomics|September 5, 2020
Nucleotide diversity of functionally different groups of immune response genes in Old World camels based on newly annotated and reference-guided assembliesSara Lado, Jean P Elbers, Mark F Rogers, et al.Gynecologic Oncology|June 4, 2019
Adjuvant chemotherapy is not associated with a survival benefit for patients with early stage mucinous ovarian carcinomaDimitrios Nasioudis, Ashley F Haggerty, Robert L Giuntoli, et al.Gynecologic Oncology Reports|June 14, 2019
Role of adjuvant chemotherapy in the management of stage IC ovarian granulosa cell tumorsDimitrios Nasioudis, Emily M Ko, Ashley F Haggerty, et al.Clinical Nephrology|April 26, 2021
Bevacizumab-associated thrombotic microangiopathy treated with eculizumab: A case series and systematic review of the literatureRachel Hilburg, Abdallah S Geara, Maylene Kefeng Qiu, et al.Data in Brief|June 4, 2020
A global cloud free pixel- based image composite from Sentinel-2 dataC Corbane, P Politis, P Kempeneers, et al.European Journal of Radiology|June 21, 2017
In-depth analysis of interreader agreement and accuracy in categorical assessment of brown adipose tissue in (18)FDG-PET/CTAnton S Becker, Caroline Zellweger, Khoschy Schawkat, et al.Journal of Gastrointestinal Oncology|May 10, 2021
Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin (PIPAC-OX) in patients with colorectal peritoneal metastases-a systematic reviewRobin J Lurvink, Koen P Rovers, Simon W Nienhuijs, et al.Journal of Virology|May 13, 2011
Activity of broadly neutralizing antibodies, including PG9, PG16, and VRC01, against recently transmitted subtype B HIV-1 variants from early and late in the epidemicZelda Euler, Evelien M Bunnik, Judith A Burger, et al.Journal of Virology|May 20, 2011
Longer V1V2 region with increased number of potential N-linked glycosylation sites in the HIV-1 envelope glycoprotein protects against HIV-specific neutralizing antibodiesMarit J van Gils, Evelien M Bunnik, Brigitte D Boeser-Nunnink, et al.Pageof 116